Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
MGI logo — Leading Life Science Innovation

MGI

Leading Life Science Innovation

Founded 2016 China Shenzhen, China 1319 employees Series B Total: $1.20B Biotechnology, Health Care +1

General Information

Company Name MGI
Founded Year 2016
Location China Shenzhen, China
Employees 1319
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Series B
Business Model B2B, D2C, Platform
Revenue Model Product Sales, Service Fee, Licensing
Social

BounceWatch is an independent company data service, not affiliated with MGI. To contact MGI, visit en.mgi-tech.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does MGI compare?

A PDF of MGI and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting MGI soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About MGI

MGI Tech Co., Ltd. (MGI) has quickly established itself as a frontrunner in the field of life sciences since its founding in 2016. With headquarters in China, the company focuses on innovations in Biotechnology, Health Care, and Life Sciences.

MGI's distinctive capability in developing and mass-producing clinical-grade gene sequencers sets it apart from competitors, addressing capacities from Gb to Tb levels, which is crucial for applications in precision medicine and other industries. The company provides a full spectrum of digital equipment for various sectors, showcasing its comprehensive approach and commitment to driving innovation.

The company's growth and strategic global presence are further bolstered by a substantial $1.00B Series B investment secured on 28 May 2020. Investors include Green Pine Capital Partners, CITIC Securities, and CPE Capital, among others, demonstrating strong financial backing and confidence in MGI's trajectory. With its cutting-edge products and global impact, MGI is well-positioned to continue shaping the future of life sciences.

Business keywords: Life Science Innovation, Gene Sequencers, Multi-omics Platforms, Precision Medicine, Genetic Sequencing, Mass Spectrometry, Medical Imaging, Digital Health Innovation, Laboratory Automation, Reagents Manufacturing, Healthcare Solutions, Laboratory Equipment, Liquid Handling Systems, Clinical-grade Sequencing

Services & Products

Sequencer Manufacturing
Genomic Data Analysis
Organoid-Based Precision Medicine
Customer Support and Resources
Genomic Research Tools

Target Customers

Research Institutions Clinical Laboratories Biotechnology Companies Healthcare Providers Genomics Researchers

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $1.00B 10
Green Pine Capital Partners CITIC Securities CPE Capital
Green Pine Capital Partners, CITIC Securities +8
28 May 2020
Series B Undisclosed -
24 Apr 2020
Series A $200.00M -
09 May 2019

Latest News

View All
US lawmakers ask FBI for briefing on GenScript Biotech’s links to China — Fijitimes.com.fj
US lawmakers ask FBI for briefing on GenScript Biotech’s links to China
Fijitimes.com.fj Jun 02, 2024

MGI Alternatives & Competitors

View All Alternatives
MGI vs
Congenica
Congenica United Kingdom

Driving Precision Medicine

Series C
24 employees
Biotechnology, Health Care
Compare MGI vs Congenica
MGI vs
Pleno Inc.
Pleno Inc. United States

Targeted biological information at unprecedented scale, precision and performance.

Series B
39 employees
Biopharma, Biotechnology
Compare MGI vs Pleno Inc.
MGI vs
ArtiQ
ArtiQ Belgium

Providing AI software to optimize clinical trials and enhance diagnostic processes to improve patie...

Acquired
20 employees
AI, Biotechnology
View all alternatives

FAQ About MGI

Leading Life Science Innovation
MGI was founded in 2016.
MGI is headquartered in Shenzhen, China.
MGI operates in Biotechnology, Health Care and Life Sciences. Its work centres on Life Science Innovation, Gene Sequencers, Multi-omics Platforms and Precision Medicine. Its customers include Research Institutions, Clinical Laboratories and Biotechnology Companies.
MGI has a B2B, D2C and Platform business model. Its revenue comes from Product Sales, Service Fee and Licensing.
MGI has approximately 1319 employees.
MGI has completed 3 funding rounds, raising a total of $1.20B. The latest funding stage is Series B.
MGI offers: Sequencer Manufacturing, Genomic Data Analysis, Organoid-Based Precision Medicine, Customer Support and Resources, Genomic Research Tools.
Top alternatives and competitors to MGI include Congenica, Pleno Inc., ArtiQ, 54gene, Phosphorus. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MGI and Congenica are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for MGI, https://bouncewatch.com/company/mgi, updated 8 April 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes